Nutraceutical Excipients Market by Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Fillers & Diluents, Disintegrants, Coating Agents), End Product, Formulation, Functionality Application and Region - Global Forecast to 2030

icon1
USD USD 7.12 Billion
MARKET SIZE, 2030
icon2
CAGR 7.4%
(2025-2030)
icon3
300
REPORT PAGES
icon4
230
MARKET TABLES

OVERVIEW

Nutraceutical Excipients Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The nutraceutical excipients market is projected to reach USD 7.12 billion by 2030, increasing from USD 4.98 billion in 2025, reflecting a strong CAGR of 7.4% during the forecast period. The rising use of excipients across dietary supplements, functional foods, and advanced nutraceutical formulations continues to be a key driver of market growth. Increasing demand for clean-label, stable, and bio-compatible ingredients is pushing manufacturers to develop innovative excipient solutions that support improved stability, taste, solubility, and bioavailability. The growing adoption of natural and plant-derived excipients across major regions, particularly in Asia Pacific, is accelerating the development of high-performance binders, fillers, coatings, and disintegrants designed for modern supplement delivery formats. These advancements are significantly enhancing product safety, efficacy, and consumer acceptance, thereby strengthening overall market expansion.

KEY TAKEAWAYS

  • BY REGION
    The North American nutraceutical excipients market accounted for a 32.2% revenue share in 2024.
  • BY SOURCE
    Among sources, organic excipients are estimated lead.
  • BY FUNCTIONALITY
    By functionality, the colorant segment is estimated to register the highest CAGR of 8.5%.
  • BY END PRODUCT
    By end product, the probiotics segment is set to dominate the market.
  • BY FORM
    By form, the dry segment is projected to grow at the fastest rate from 2025 to 2030.
  • BY FUNCTIONALITY APPLICATION
    By functionality application, the taste masking segment is poised to register the highest CAGR of 7.9%.
  • COMPETITIVE LANDSCAPE (Key Players)
    Key players such as Kerry Group, BASF SE, Cargill Incorporated, Lubrizol Life Science, and DFE Pharma focus on capacity expansions, product innovations, and sustainable manufacturing technologies in the nutraceutical excipients market. Companies are also investing in research for bio-based and functional excipients and forming strategic partnerships to strengthen their regional presence and cater to a diverse range of dietary supplement and functional food applications.
  • COMPETITIVE LANDSCAPE (SME)
    Innophos, JRS PHARMA, Omya AG, Daicel Corporation, Alsiano A/S, and Colorcon have distinguished themselves within the SME landscape by building strong footholds in specialized excipient niches, underscoring their potential as emerging market leaders.

The nutraceutical excipients market is entering a dynamic growth phase as evolving consumer preferences, advanced supplement formulation needs, and the global shift toward natural, high-performance ingredients drive strong industry expansion. With rising demand for functional foods, dietary supplements, and innovative delivery formats such as gummies, soft gels, and effervescent tablets, manufacturers increasingly rely on specialized excipients to enhance stability, taste, solubility, and bioavailability. The move toward clean-label formulations and plant-derived alternatives is further reshaping the competitive landscape, encouraging continuous innovation in binders, fillers, coatings, disintegrants, and other functional components. As brands focus on improving shelf life, nutrient protection, and overall product efficacy, the demand for robust and scientifically optimized excipients is accelerating across both developed and emerging markets, positioning the sector for sustained long-term growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The nutraceutical excipients market is being shaped by a strong shift toward clean-label, natural, and plant-derived excipients, driven by rising consumer transparency demands. Manufacturers are increasingly adopting multifunctional excipients that improve compressibility, stability, and bioavailability while reducing formulation complexity. Advances in modified-release, nano-encapsulation, and protective coating technologies are disrupting traditional excipient use by enabling better delivery of sensitive ingredients like probiotics and omega-3s. The market is also witnessing rapid movement toward TiO2-free coatings and allergen-free alternatives due to regulatory pressures. Additionally, expansion of vegan softgel systems and plant-based polymers is accelerating the transition away from animal-derived excipients, reshaping product development strategies across nutraceutical brands.

Nutraceutical Excipients Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising global demand for dietary supplements & functional foods
  • Growing health-awareness and preventive healthcare trends
RESTRAINTS
Impact
Level
  • Significant R&D and formulation development costs
  • High cost of specialty / clean-label excipient grades
OPPORTUNITIES
Impact
Level
  • Development of plant-based/clean-label excipients
  • Expansion into personalized nutrition & targeted-release systems
CHALLENGES
Impact
Level
  • Regulatory uncertainty and differing regional requirement
  • High cost and lead time for validation/qualification

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising global demand for dietary supplements & functional foods

Rising global demand for dietary supplements and functional foods is becoming a key driver for the nutraceutical excipients market, supported by recent government-backed data and consumption trends. According to the US CDC’s NHANES survey (August 2021–August 2023), dietary supplement use remains widespread, with over 57% of adults reporting supplement intake, while multi-supplement usage among adults aged 20–59 increased to 30.8% in the 2021–2023 cycle. This steady rise in supplement consumption directly accelerates the need for high-performance excipients that enhance stability, bioavailability, solubility, and taste. In parallel, the Ministry of Food Processing Industries (India) reported in 2023 that functional foods and beverages account for over one-third of the country’s nutraceutical market, reflecting strong consumer adoption of fortified and value-added foods. As governments continue to highlight nutrition, wellness, and preventive health, this expanding consumption base strengthens demand for innovative nutraceutical excipients, positioning them as crucial enablers of product performance and market growth.

Restraint: Significant R&D and formulation development costs

Significant R&D and formulation development costs act as a major restraint for the nutraceutical excipients market, particularly as companies increasingly pursue advanced delivery systems, clean-label solutions, and multifunctional excipients. Developing high-performance excipients such as those supporting modified release, taste masking, enhanced solubility, or stability requires substantial investment in scientific research, pilot-scale testing, regulatory documentation, and compatibility studies with diverse nutraceutical actives. Smaller manufacturers often struggle to absorb these costs, limiting their ability to innovate or adopt next-generation excipients. Additionally, the need for continuous reformulation to meet evolving regulatory standards, regional compliance requirements, and consumer expectations further increases development expenses. High costs associated with specialized equipment, analytical testing, and quality assurance also contribute to slower market entry and reduced product affordability. As a result, these financial barriers may constrain innovation, delay commercialization timelines, and limit wider adoption of advanced excipient technologies across the nutraceutical industry.

Opportunity: Development of plant-based/clean-label excipients

The growing development of plant-based and clean-label excipients presents a significant opportunity for the nutraceutical excipients market, reinforced by rising global demand for natural, sustainable, and transparent formulations. The systematic review published on November 19, 2024, highlights how plant-derived materials such as cellulose, starch, carrageenan, guar gum, and plant oils are increasingly preferred for their biocompatibility, safety, and alignment with green chemistry principles. As consumers move toward chemical-free, vegan, and eco-friendly supplements, manufacturers are accelerating the adoption of these clean-label excipients to improve stability, solubility, texture, and controlled-release performance in nutraceutical products. This trend opens strong innovation pathways in allergen-free, non-GMO, and biodegradable excipient solutions. Additionally, advancements in extraction and purification technologies are making plant-based excipients more scalable and cost-efficient. With sustainability now central to product development strategies, plant-based excipients represent a high-growth opportunity for companies aiming to meet evolving regulatory and consumer expectations.

Challenge: Regulatory uncertainty and differing regional requirement

Regulatory uncertainty and differing regional requirements pose a significant challenge for the nutraceutical excipients market, primarily because excipient standards are not harmonized across major markets. Nutraceuticals often fall between food and pharmaceutical regulations, and each region, such as the US, EU, India, and Asia Pacific, applies different rules for safety, purity, permitted additives, and labeling. This inconsistency makes it difficult for manufacturers to develop formulations that meet all regional compliance expectations without extensive reformulation or multiple approval cycles. Moreover, several countries lack clear frameworks for novel or functional excipients, creating delays in market entry and increasing the cost of product development. Frequent regulatory updates and unclear classification of excipients further add to compliance risks, especially for innovative or plant-based materials. As a result, companies face higher documentation burdens, complex quality-control requirements, and increased R&D costs, slowing down innovation and limiting the ability to launch standardized global products in the nutraceutical excipients market.

Nutraceutical Excipients Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Advanced coating systems, controlled-release polymers, and film-forming excipients for nutraceutical tablets and capsules Improved product stability, enhanced swallowing experience, uniform appearance, and better release control for active ingredients
Taste-masking excipients, functional binders, and delivery matrix systems for powders, gummies, and functional beverages Superior palatability, consistent texture, improved consumer acceptance, and enhanced dispersion in liquid formats
Pharma-grade binders, disintegrants, and solubilizers for high-potency nutraceutical formulations Enhanced bioavailability, faster disintegration, improved shelf-life, and reliable performance in complex formulations
Plant-based excipients such as pea starches, polyols, and natural binders for a clean-label nutraceutical product Clean-label positioning, improved compressibility, better formulation flexibility, and strong alignment with vegan and natural trends

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The nutraceutical excipients market ecosystem comprises interconnected relationships among key stakeholders, including raw material suppliers, excipient manufacturers, distributors, and end users across various industries such as dietary supplements, functional foods, beverages, and personal care. Raw material suppliers provide plant-based, organic chemical, mineral, or bio-derived ingredients used in the production of functional excipients. Manufacturers convert these raw materials into excipients such as binders, stabilizers, emulsifiers, flavoring agents, and taste-masking agents, which are further processed for incorporation into vitamins, protein powders, herbal formulations, and nutraceutical products. Distributors and suppliers act as intermediaries, connecting producers with end users such as supplement manufacturers, functional food companies, and beverage formulators, thereby optimizing the supply chain to enhance product availability, quality, and operational efficiency across global markets.

Nutraceutical Excipients Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Nutraceutical Excipients Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Nutraceutical Excipients Market, By End Product

Probiotics represent the largest sub-segment within the end-product segment of the nutraceutical excipients market, driven by increasing consumer demand for digestive health and immunity-supporting supplements. The growing popularity of probiotic supplements has encouraged manufacturers to develop excipients that enhance the stability, shelf life, and organoleptic properties of these sensitive bioactive ingredients. A recent example is Roquette’s launch of PEARLITOL ProTec on May 18, 2023, a plant-based co-processed excipient combining mannitol and maize starch, designed specifically to protect moisture-sensitive probiotics and maintain product consistency. This innovation addresses key formulation challenges, allowing manufacturers to offer diverse, consumer-friendly dosage formats while meeting stringent regulatory standards across major markets.

Nutraceutical Excipients Market, By Functionality

Coating agents continue to dominate the functionality segment of the nutraceutical excipients market, driven by their critical role in enhancing product stability, appearance, and consumer appeal across tablets and capsules. These excipients not only protect active ingredients from environmental stressors such as moisture and light but also improve swallowability and mask unpleasant tastes, ensuring better patient and consumer compliance. A recent example of innovation in this segment is Colorcon’s launch of Nutracore on April 18, 2023, a range of label-friendly coating excipients designed specifically for nutritional and dietary supplements. Nutracore materials are formulated from natural ingredients, combining flowability, compressibility, and lubricity to simplify manufacturing while meeting clean-label and sustainability demands. By offering consistent performance, ease of application, and cost-effectiveness, coating agents like Nutracore enable supplement manufacturers to create high-quality, consumer-friendly products without compromising on functional efficiency. The launch underscores the strategic importance of coating excipients in the nutraceutical sector, highlighting how innovations in this space are key to addressing evolving consumer preferences and driving the growth of the functionality sub-segment.

Nutraceutical Excipients Market, By Functionality Application

Stabilizers have emerged as the dominating sub-segment within the functionality application segment of the nutraceutical excipients market, owing to their essential role in maintaining the integrity, efficacy, and shelf life of sensitive bioactive compounds. These excipients are particularly critical in probiotic and other moisture-sensitive formulations, where environmental factors such as temperature, humidity, and processing conditions can compromise product stability. A notable example is Balchem’s launch of StabiliPro on October 15, 2025, a new portfolio of excipients designed specifically to stabilize probiotics and extend their shelf life. StabiliPro minimizes the need for overages, ensuring that functional food, beverage, and dietary supplement innovators can deliver cost-effective formulations that meet consumer expectations for quality and clean-label solutions. By preserving probiotic viability and overcoming processing challenges, stabilizers like StabiliPro are pivotal in addressing formulation hurdles, regulatory compliance, and consumer demand for effective, reliable supplements. This launch underscores the strategic importance of stabilizers, highlighting their central role in driving growth and innovation within the functionality segment of the nutraceutical excipients market.

REGION

North America to be dominating region in global nutraceutical excipients market during forecast period

North America continues to dominate the nutraceutical excipients market, supported by a strong pace of product innovation and launches across the US. In April 2023, Colorcon introduced its Nutracore™ range of label-friendly excipients specifically formulated for nutritional tablets and capsules, reflecting the region’s push toward clean-label formulations. This was followed by the launch of Colorcon’s Nutrafinish® TiO2-free high-productivity coating in October 2023, designed to meet growing regulatory and consumer demands for titanium-dioxide-free supplements. More recently, in May 2025, Roquette strengthened its North American footprint by expanding its excipient and drug-delivery capabilities through the completion of its acquisition of IFF Pharma Solutions, enhancing access to advanced plant-based and modified-release excipient technologies. These timely advancements highlight how continuous innovations and rapid adoption of new excipient systems in the US reinforce North America’s position as the leading and most dynamic region in the nutraceutical excipients market.

Nutraceutical Excipients Market Region

Nutraceutical Excipients Market: COMPANY EVALUATION MATRIX

In the nutraceutical excipients market, key companies profiled include Colorcon, Inc., Roquette Frères, BASF SE, Ashland Global Holdings, Kerry Group plc, Ingredion Incorporated, DuPont Nutrition & Biosciences, ADM, DFE Pharma, Sensient Technologies Corporation, Gattefossé, Meggle Group, JRS Pharma, FMC Corporation, and Evonik Industries AG.

Nutraceutical Excipients Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size, 2024 (Value) USD 4.63 Billion
Market Forecast, 2030 (Value) USD 7.12 Billion
Growth Rate CAGR of 7.4% from 2025 to 2030
Years Considered 2020–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Thousand), Volume (Metric Tons)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • Source:
    • Organic Chemicals
    • Inorganic Chemicals
    • Other Sources
  • Functionality:
    • Fillers & Diluents
    • Suspending & Viscosity Agnts
    • Coating agents
    • Binders
    • Flavoring Agents & Sweeteners
    • Disintegrants
    • Colorants
    • Lubricants & Glidants
    • Preservatives
    • Emulsifying Agents
    • Other Functionalities
  • End Product:
    • Proteins & Amino Acids
    • Omega-3 Fatty Acids
    • Vitamins
    • Minerals
    • Prebiotics
    • Probiotics
    • Other End Products
  • Form:
    • Dry
    • Liquid
  • Functionality Application:
    • Taste Masking
    • Stabilizers
    • Modified Release
    • Solubility & Bioavailability Enhancers
    • Other Functionality Applications
Regions Covered North America, Asia Pacific, Europe, South America, Rest of the World

WHAT IS IN IT FOR YOU: Nutraceutical Excipients Market REPORT CONTENT GUIDE

Nutraceutical Excipients Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Global nutraceutical manufacturer needed detailed excipient demand projections across dosage forms Forecasting of binders, fillers, disintegrants, lubricants, coating agents, solubilizers, and taste-masking systems across tablets, capsules, softgels, gummies, and powders Enabled precise sourcing, efficient production planning, and better alignment with global supplement trends
Plant-based nutrition brand required evaluation of natural and vegan excipients Functional assessment of plant-derived starches, gums, fibers, and natural polymers for clean-label and allergen-free formulations Improved texture and stability, strengthened clean-label claims, and reduced reliance on synthetic additives
Sports nutrition & beverage company needed a performance analysis of excipients in RTDs and powders Mapping of excipients enhancing instantization, dispersibility, emulsification, and mouthfeel Delivered superior product performance, enhanced solubility, and improved consumer experience
Pharma-nutrition hybrid company required advanced excipient application insights Evaluation of pharma-grade excipients such as microencapsulation agents, controlled-release polymers, and solubility enhancers for nutraceutical use Increased bioavailability, extended shelf stability, and ensured compliance with regulatory expectations
Contract manufacturing organization (CMO) needed supplier benchmarking to expand capacity Analysis of global excipient suppliers, production capacity mapping, pricing trends, and quality certifications Supported cost optimization, secure supplier selection, and expansion into high-growth supplement formats
Functional food company needed guidance on excipient performance in fortified foods Assessment of stabilizers, emulsifiers, and anti-caking agents for bars, beverages, and powdered mixes Enhanced product uniformity, reduced formulation failures, and improved shelf consistency
Herbal supplement brand required optimization of moisture-sensitive formulations Screening of low-moisture binders, protective coating systems, and desiccation-friendly fillers Reduced degradation of botanical actives, improved shelf life, and ensured potency retention
Gummy supplement manufacturer needed insights on texture & stability enhancers Evaluation of pectin, gelatin alternatives, starch systems, and natural sweetener-compatible excipients Delivered consistent chewiness, minimized sticking, and improved heat stability during transport
Softgel manufacturer required excipient support for challenging lipid-based actives Profiling solubilizers, antioxidants, and shell-stability enhancers for lipid systems Improved encapsulation efficiency, greater active retention, and enhanced oxidative stability
Start-up brand needed regulatory alignment for excipients used in new supplement formats Mapping of FDA, EFSA, and FSSAI regulatory approvals, allowable limits, and clean-label compliance Ensured faster go-to-market, reduced regulatory risk, and improved label transparency

RECENT DEVELOPMENTS

  • October 2025 : Balchem launched its StabiliPro™ excipient portfolio focused on enhancing probiotic stability in supplements and functional foods. The range helped maintain probiotic viability during processing and storage, minimizing the need for overages. It would align with clean-label expectations and support long-term shelf-life requirements. This launch strengthened Balchem’s position in specialized stabilization excipients for nutraceuticals.
  • May 2024 : Roquette introduced LYCAGEL® Flex, a plant-based softgel capsule excipient based on hydroxypropyl pea starch. The system enabled manufacturers to choose tailored plasticizer combinations, improving capsule flexibility, stability, and performance. It also supported cleaner processing with faster degassing and easier equipment cleaning. The innovation expanded Roquette’s offerings for vegan and allergen-free nutraceutical capsules.
  • April 2023 : Colorcon launched its NutraCore™ range of label-friendly binders, fillers, and lubricants designed for nutritional products. These excipients used natural, consumer-preferred ingredients while ensuring excellent tableting and encapsulation performance. The platform helped manufacturers meet clean-label demands without compromising manufacturability. This expansion reinforced Colorcon’s leadership in natural excipient solutions.
  • April 2023 : Colorcon introduced a TiO2-free Nutrafinish® moisture-protection coating for humidity-sensitive nutraceutical tablets. The coating delivered strong moisture resistance while avoiding titanium dioxide, aligning with global regulatory shifts. It supported brands transitioning to cleaner label formats without sacrificing stability. The product enhanced both tablet protection and consumer acceptance.
  • October 2023 : Colorcon launched a high-productivity, TiO2-free Nutrafinish® coating designed for large-scale supplement manufacturing. The system provided high opacity and fast processing, improving efficiency on high-speed coating lines. It allowed manufacturers to eliminate titanium dioxide while preserving tablet appearance and performance. This development further expanded Colorcon’s clean-label coating portfolio.

 

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
35
2
EXECUTIVE SUMMARY
 
 
 
 
 
41
3
PREMIUM INSIGHTS
 
 
 
 
 
48
4
MARKET OVERVIEW
Nanotechnology and clean-label trends drive nutraceutical innovations amid regulatory and consumer shifts.
 
 
 
 
 
53
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASED FOCUS ON PREVENTIVE CARE TO ENCOURAGE INVESTMENTS IN PRODUCTS/SOLUTIONS
 
 
 
 
 
 
4.2.1.2
ADVANCEMENTS IN NANOTECHNOLOGY EQUIPPED WITH NEW FEATURES RELATING TO NUTRACEUTICAL EXCIPIENTS
 
 
 
 
 
 
4.2.1.3
RISING INVESTMENTS IN CLEAN-LABEL AND NATURAL EXCIPIENTS DRIVEN BY REGULATORY PRESSURE AND SHIFTING CONSUMER HEALTH PREFERENCES
 
 
 
 
 
 
4.2.1.4
MANDATES ON FOOD FORTIFICATION BY GOVERNMENT ORGANIZATIONS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
DECREASE IN RETURNS ON R&D INVESTMENTS AND HIGH COSTS OF CLINICAL TRIALS AND REGISTRATION
 
 
 
 
 
 
4.2.2.2
STRINGENT REGULATORY EXPECTATIONS FOR EXCIPIENT SAFETY, PURITY, AND COMPLIANCE, ADDING COMPLEXITY TO PRODUCT APPROVALS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
MULTI-FUNCTIONALITIES OF EXCIPIENTS AIDING IN SAVING COSTS AND PROCESSING TIME
 
 
 
 
 
 
4.2.3.2
RISING AWARENESS OF MICRONUTRIENT DEFICIENCIES
 
 
 
 
 
 
4.2.3.3
GROWING POPULARITY OF GUMMY SUPPLEMENTS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
CONSUMER SKEPTICISM ASSOCIATED WITH NUTRACEUTICAL PRODUCTS DUE TO RURAL AND SEMI-URBAN CONSUMERS’ PERCEPTION OF DIETARY SUPPLEMENTS AS PHARMACEUTICAL DRUGS
 
 
 
 
 
 
4.2.4.2
ENSURING COMPATIBILITY WITH HIGH-POTENCY ACTIVES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive pressures and capitalize on rising nutraceutical demand amidst evolving global demographics.
 
 
 
 
 
67
 
5.1
INTRODUCTION
 
 
 
 
 
 
5.2
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.2.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.2.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.2.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.2.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.2.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.3
MACROECONOMIC INDICATORS
 
 
 
 
 
 
 
5.3.1
GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
 
 
 
 
 
 
5.3.2
AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS
 
 
 
 
 
5.4
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
SOURCING OF RAW MATERIALS
 
 
 
 
 
 
5.5.2
MANUFACTURING
 
 
 
 
 
 
5.5.3
DISTRIBUTION, MARKETING, AND SALES
 
 
 
 
 
5.6
ECOSYSTEM/MARKET MAP
 
 
 
 
 
 
 
 
5.6.1
UPSTREAM
 
 
 
 
 
 
 
5.6.1.1
EXCIPIENT MANUFACTURERS
 
 
 
 
 
 
5.6.1.2
TECHNOLOGY PROVIDERS
 
 
 
 
 
5.6.2
DOWNSTREAM
 
 
 
 
 
 
 
5.6.2.1
REGULATORY BODIES
 
 
 
 
 
 
5.6.2.2
NUTRACEUTICAL MANUFACTURERS
 
 
 
 
5.7
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
INDICATIVE AVERAGE SELLING PRICE, BY SOURCE
 
 
 
 
 
 
5.7.2
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
 
 
5.8
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.8.1
TRADE ANALYSIS OF HS CODE 210690
 
 
 
 
 
 
 
5.8.1.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 210690
 
 
 
 
 
 
5.8.1.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690
 
 
 
 
 
5.8.2
TRADE ANALYSIS OF HS CODE 300490
 
 
 
 
 
 
 
5.8.2.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490
 
 
 
 
 
 
5.8.2.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490
 
 
 
 
 
5.8.3
TRADE ANALYSIS OF HS CODE 293090
 
 
 
 
 
 
 
5.8.3.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 293090
 
 
 
 
 
 
5.8.3.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090
 
 
 
 
 
5.8.4
TRADE ANALYSIS OF HS CODE 382200
 
 
 
 
 
 
 
5.8.4.1
EXPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200
 
 
 
 
 
 
5.8.4.2
IMPORT TRENDS OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200
 
 
 
 
5.9
KEY CONFERENCES & EVENTS
 
 
 
 
 
 
5.10
TRENDS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.11
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.12
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.12.1
BENEO’S GALENIQ® MULTIFUNCTIONAL FILLER-BINDER FOR CLEAN-LABEL TABLETS (CPHI 2025)
 
 
 
 
 
 
5.12.2
ROQUETTE READILYCOAT® LOW-TEMPERATURE COATING SYSTEM (2025)
 
 
 
 
 
 
5.12.3
EVONIK – LIPID-BASED CARRIER FOR OMEGA-3 CAPSULES (APRIL 2024)
 
 
 
 
 
5.13
IMPACT OF 2025 US TARIFF - NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
 
 
5.13.1
INTRODUCTION
 
 
 
 
 
 
5.13.2
KEY TARIFF RATES
 
 
 
 
 
 
5.13.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.13.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
5.13.5
IMPACT ON END-USE INDUSTRY
 
 
 
 
6
STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS
Harness AI and patents to revolutionize nutraceutical excipients with strategic tech disruptions.
 
 
 
 
 
93
 
6.1
INTRODUCTION
 
 
 
 
 
 
6.2
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.5.1
LIST OF MAJOR PATENTS
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
 
 
6.7.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.7.2
BEST PRACTICES IN NUTRACEUTICAL EXCIPIENT PROCESSING
 
 
 
 
 
 
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
 
6.7.3.1
AI-DRIVEN INGREDIENT DISCOVERY & FORMULATION OPTIMIZATION
 
 
 
 
 
 
6.7.3.2
AI-ENABLED EVIDENCE REVIEW AND PRODUCT RATIONALIZATION (2025)
 
 
 
 
 
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
6.8
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
Navigate global nutraceutical regulations with insights on regional compliance and sustainability initiatives.
 
 
 
 
 
109
 
7.1
INTRODUCTION
 
 
 
 
 
 
7.2
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.2.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.2.2
INDUSTRY STANDARDS
 
 
 
 
 
 
 
7.2.2.1
ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
7.2.2.2
NORTH AMERICA
 
 
 
 
 
 
 
 
7.2.2.2.1
CANADA
 
 
 
 
 
 
7.2.2.2.2
US
 
 
 
 
 
 
7.2.2.2.3
MEXICO
 
 
 
 
7.2.2.3
EUROPEAN UNION (EU)
 
 
 
 
 
 
7.2.2.4
ASIA PACIFIC
 
 
 
 
 
 
 
 
7.2.2.4.1
JAPAN
 
 
 
 
 
 
7.2.2.4.2
CHINA
 
 
 
 
 
 
7.2.2.4.3
INDIA
 
 
 
 
 
 
7.2.2.4.4
AUSTRALIA & NEW ZEALAND
 
 
 
 
7.2.2.5
REST OF THE WORLD (ROW)
 
 
 
 
 
 
 
 
7.2.2.5.1
BRAZIL
 
 
 
 
7.2.2.6
PROBIOTICS
 
 
 
 
 
 
 
 
7.2.2.6.1
INTRODUCTION
 
 
 
 
 
 
7.2.2.6.2
NATIONAL/INTERNATIONAL BODIES FOR SAFETY STANDARDS AND REGULATIONS
 
 
 
 
 
 
7.2.2.6.3
CODEX ALIMENTARIUS COMMISSION (CAC)
 
 
 
 
 
 
7.2.2.6.4
NORTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS
 
 
 
 
 
 
7.2.2.6.5
ASIA PACIFIC: REGULATORY ENVIRONMENT ANALYSIS
 
 
 
 
 
 
7.2.2.6.6
SOUTH AMERICA: REGULATORY ENVIRONMENT ANALYSIS
 
 
 
 
7.2.2.7
PREBIOTICS
 
 
 
 
 
 
 
 
7.2.2.7.1
INTRODUCTION
 
 
 
 
 
 
7.2.2.7.2
ASIA PACIFIC
 
 
 
 
 
 
7.2.2.7.3
NORTH AMERICA
 
 
 
 
 
 
7.2.2.7.4
EUROPEAN UNION
 
 
7.3
SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
 
7.3.1
ADOPTION OF PLANT-BASED AND UPCYCLED RAW MATERIALS
 
 
 
 
 
 
7.3.2
IMPLEMENTATION OF ENERGY-EFFICIENT PROCESSING TECHNOLOGIES
 
 
 
 
 
7.4
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
 
 
 
 
 
 
7.5
CERTIFICATIONS, LABELING, ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Discover how unmet needs and stakeholder influence shape nutraceutical buying decisions and market profitability.
 
 
 
 
 
130
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.3
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
 
9
NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
 
 
 
 
 
136
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
PROBIOTICS
 
 
 
 
 
 
 
9.2.1
GROWING STABILITY REQUIREMENTS OF PROBIOTIC INGREDIENTS TO DRIVE MARKET
 
 
 
 
 
9.3
PREBIOTICS
 
 
 
 
 
 
 
9.3.1
INCREASING FORMULATION NEEDS FOR STABLE PREBIOTIC INGREDIENTS TO DRIVE MARKET
 
 
 
 
 
9.4
PROTEINS & AMINO ACIDS
 
 
 
 
 
 
 
9.4.1
GROWING FORMULATION REQUIREMENTS FOR STABLE PROTEIN AND AMINO ACID INGREDIENTS TO DRIVE MARKET
 
 
 
 
 
9.5
VITAMINS
 
 
 
 
 
 
 
9.5.1
PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
 
 
 
 
 
9.6
MINERALS
 
 
 
 
 
 
 
9.6.1
BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
9.7
OMEGA-3 FATTY ACIDS
 
 
 
 
 
 
 
9.7.1
INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACID SUPPLEMENTS
 
 
 
 
 
9.8
OTHER END PRODUCTS
 
 
 
 
 
10
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 24 Data Tables
 
 
 
 
 
148
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
ORGANIC CHEMICALS
 
 
 
 
 
 
 
10.2.1
OLEOCHEMICALS
 
 
 
 
 
 
 
10.2.1.1
FATTY ALCOHOLS
 
 
 
 
 
 
 
 
10.2.1.1.1
NEED FOR ENHANCING TEXTURE AND CREAMINESS LIKELY TO PROPEL DEMAND
 
 
 
 
10.2.1.2
MINERAL STEARATES
 
 
 
 
 
 
 
 
10.2.1.2.1
MINERAL STEARATES TO REDUCE FRICTION AND AVOID EQUIPMENT CLOGGING DURING MANUFACTURING OF NUTRACEUTICALS
 
 
 
 
10.2.1.3
GLYCERIN
 
 
 
 
 
 
 
 
10.2.1.3.1
GLYCERIN TO HELP IMPROVE SMOOTHNESS AND LUBRICATION PROCESS
 
 
 
 
10.2.1.4
OTHER OLEOCHEMICALS
 
 
 
 
 
10.2.2
CARBOHYDRATES
 
 
 
 
 
 
 
10.2.2.1
SUGARS
 
 
 
 
 
 
 
 
10.2.2.1.1
ACTUAL SUGARS
 
 
 
 
 
 
10.2.2.1.2
SUGAR ALCOHOLS
 
 
 
 
 
 
10.2.2.1.3
ARTIFICIAL SWEETENERS
 
 
 
 
10.2.2.2
CELLULOSE
 
 
 
 
 
 
 
 
10.2.2.2.1
MICROCRYSTALLINE CELLULOSE
 
 
 
 
 
 
10.2.2.2.2
CELLULOSE ETHERS
 
 
 
 
 
 
10.2.2.2.3
CMC & CROSCARMELLOSE SODIUM
 
 
 
 
 
 
10.2.2.2.4
CELLULOSE ESTERS
 
 
 
 
10.2.2.3
STARCH
 
 
 
 
 
 
 
 
10.2.2.3.1
MODIFIED STARCH
 
 
 
 
 
 
10.2.2.3.2
DRIED STARCH
 
 
 
 
 
 
10.2.2.3.3
CONVERTED STARCH
 
 
 
10.2.3
PETROCHEMICALS
 
 
 
 
 
 
 
10.2.3.1
GLYCOLS
 
 
 
 
 
 
 
 
10.2.3.1.1
HUMECTANT & SOLVENT PROPERTIES TO DRIVE DEMAND
 
 
 
 
10.2.3.2
POVIDONES
 
 
 
 
 
 
 
 
10.2.3.2.1
FILM-FORMING FUNCTION TO PROVIDE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
 
 
 
 
10.2.3.3
MINERAL HYDROCARBONS
 
 
 
 
 
 
 
 
10.2.3.3.1
PROPERTIES SUCH AS ANTIFOAMING AND LUBRICATION TO HELP IN NUTRACEUTICAL MANUFACTURING
 
 
 
 
10.2.3.4
ACRYLIC POLYMERS
 
 
 
 
 
 
 
 
10.2.3.4.1
DIVERSE FUNCTIONS OF ACRYLIC POLYMERS IN NUTRACEUTICALS TO PROPEL GROWTH
 
 
 
 
10.2.3.5
OTHER PETROCHEMICAL EXCIPIENTS
 
 
 
 
 
10.2.4
PROTEINS
 
 
 
 
 
 
 
10.2.4.1
EXPANDING UTILIZATION OF PROTEINS AS CARRIERS FOR MICROPARTICLES AND NANOPARTICLES TO PROPEL MARKET GROWTH
 
 
 
 
 
10.2.5
OTHER ORGANIC CHEMICALS
 
 
 
 
 
10.3
INORGANIC CHEMICALS
 
 
 
 
 
 
 
10.3.1
CALCIUM PHOSPHATE
 
 
 
 
 
 
 
10.3.1.1
NUTRACEUTICAL PRODUCTION TO BE OPTIMIZED BY UTILIZING GMO-FREE CALCIUM PHOSPHATES AS GRAS EXCIPIENTS
 
 
 
 
 
10.3.2
METAL OXIDES
 
 
 
 
 
 
 
10.3.2.1
METAL OXIDES TO HELP MEET RISING DEMAND FOR IRON-ENRICHED NUTRACEUTICALS
 
 
 
 
 
10.3.3
HALITES
 
 
 
 
 
 
 
10.3.3.1
HALITES TO ENSURE TASTE IMPROVEMENT AND SALTING-OUT TECHNIQUES
 
 
 
 
 
10.3.4
CALCIUM CARBONATE
 
 
 
 
 
 
 
10.3.4.1
FOCUS ON R&D OF CALCIUM CARBONATE TO HELP LAUNCH NEW PRODUCTS
 
 
 
 
 
10.3.5
CALCIUM SULFATE
 
 
 
 
 
 
 
10.3.5.1
IMPROVED FLOWABILITY TO DRIVE DEMAND FOR CALCIUM SULFATE
 
 
 
 
 
10.3.6
OTHER INORGANIC CHEMICALS
 
 
 
 
 
10.4
OTHER CHEMICALS
 
 
 
 
 
11
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 12 Data Tables
 
 
 
 
 
170
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
TASTE MASKING
 
 
 
 
 
 
 
11.2.1
CREATING DIFFERENTIATION IS KEY IN THIS COMPETITIVE MARKET
 
 
 
 
 
11.3
STABILIZERS
 
 
 
 
 
 
 
11.3.1
MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS
 
 
 
 
 
11.4
MODIFIED RELEASE
 
 
 
 
 
 
 
11.4.1
NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATIONS IN NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
11.5
SOLUBILITY & BIOAVAILABILITY ENHANCEMENT
 
 
 
 
 
 
 
11.5.1
CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND
 
 
 
 
 
11.6
OTHER FUNCTIONALITY APPLICATIONS
 
 
 
 
 
12
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 10 Data Tables
 
 
 
 
 
178
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
DRY
 
 
 
 
 
 
 
12.2.1
TABLETS
 
 
 
 
 
 
 
12.2.1.1
EASY-TO-CARRY AND PORTABLE NATURE MAKES THEM ATTRACTIVE OPTION
 
 
 
 
 
12.2.2
CAPSULES
 
 
 
 
 
 
 
12.2.2.1
QUICK-DISSOLVING CAPSULE SHELLS FOR TARGETED ABSORPTION ARE IDEAL FOR NUTRACEUTICALS DESIGNED TO ACT IN SPECIFIC AREAS OF DIGESTIVE TRACT
 
 
 
 
12.3
LIQUID
 
 
 
 
 
 
 
12.3.1
POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH
 
 
 
 
 
12.4
OTHER FORMULATIONS
 
 
 
 
 
13
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 24 Data Tables
 
 
 
 
 
185
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
BINDERS
 
 
 
 
 
 
 
13.2.1
INCREASED ACCEPTANCE AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
13.3
FILLERS & DILUENTS
 
 
 
 
 
 
 
13.3.1
USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS
 
 
 
 
 
13.4
DISINTEGRANTS
 
 
 
 
 
 
 
13.4.1
HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT
 
 
 
 
 
13.5
COATING AGENTS
 
 
 
 
 
 
 
13.5.1
PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND
 
 
 
 
 
13.6
FLAVORING AGENTS & SWEETENERS
 
 
 
 
 
 
 
13.6.1
INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT
 
 
 
 
 
13.7
PRESERVATIVES
 
 
 
 
 
 
 
13.7.1
INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES
 
 
 
 
 
13.8
LUBRICANTS & GLIDANTS
 
 
 
 
 
 
 
13.8.1
INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT
 
 
 
 
 
13.9
SUSPENDING & VISCOSITY AGENTS
 
 
 
 
 
 
 
13.9.1
PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT
 
 
 
 
 
13.10
COLORANTS
 
 
 
 
 
 
 
13.10.1
NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS
 
 
 
 
 
13.11
EMULSIFYING AGENTS
 
 
 
 
 
 
 
13.11.1
NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS
 
 
 
 
 
13.12
OTHER FUNCTIONALITIES
 
 
 
 
 
14
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 14 Countries | 102 Data Tables.
 
 
 
 
 
200
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
 
 
14.2.1.1
HIGH CONCENTRATION OF KEY PLAYERS, VARIOUS NUTRITION AWARENESS PROGRAMS, AND INCREASE IN PREVENTIVE HEALTHCARE TRENDS IN US
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
 
 
14.2.2.1
DEMAND FOR QUALITY AND COST-COMPETITION: TWO KEY FACTORS FOR MANUFACTURERS TO CONSIDER IN CANADA
 
 
 
 
 
14.2.3
MEXICO
 
 
 
 
 
 
 
14.2.3.1
INCREASE IN FOREIGN DIRECT INVESTMENTS AND RISE IN AWARENESS REGARDING HEALTHIER LIFESTYLES ASSOCIATED WITH DIETARY SUPPLEMENTS
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
 
 
 
14.3.1.1
DEMAND FOR NUTRACEUTICAL EXCIPIENTS IS LIKELY TO INCREASE TO SERVE HEALTH-CONSCIOUS CONSUMERS
 
 
 
 
 
14.3.2
FRANCE
 
 
 
 
 
 
 
14.3.2.1
INNOVATIONS IN PRODUCT FORMULATIONS TO CATER TO INCREASED CONSUMER DEMANDS
 
 
 
 
 
14.3.3
UK
 
 
 
 
 
 
 
14.3.3.1
GROWTH OF FUNCTIONAL/FORTIFIED FOOD & BEVERAGE INDUSTRY IN UK TO DRIVE DEMAND FOR NUTRACEUTICAL EXCIPIENTS
 
 
 
 
 
14.3.4
ITALY
 
 
 
 
 
 
 
14.3.4.1
GROWING TREND OF ONLINE OTC AND FOOD SUPPLEMENT PURCHASES IN ITALY
 
 
 
 
 
14.3.5
SPAIN
 
 
 
 
 
 
 
14.3.5.1
EXCIPIENT MANUFACTURERS EXPAND IBERIAN OPERATIONS TO SUPPORT TABLETS AND CAPSULES MARKETED ACROSS SPAIN
 
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
 
14.4.1
CHINA
 
 
 
 
 
 
 
14.4.1.1
RISE IN PREFERENCE FOR NUTRACEUTICAL PRODUCTS AND INNOVATIONS IN DIETARY SUPPLEMENT FORMULATIONS AND FORTIFIED FOOD PRODUCTS
 
 
 
 
 
14.4.2
JAPAN
 
 
 
 
 
 
 
14.4.2.1
MANUFACTURERS SHOULD THINK BEYOND PILLS & INNOVATION TO TAP THIS GROWING MARKET IN JAPAN
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
 
 
14.4.3.1
GOVERNMENT POLICIES AND IMPORTANCE OF NUTRACEUTICALS IN DAILY LIFE
 
 
 
 
 
14.4.4
SOUTH KOREA
 
 
 
 
 
 
 
14.4.4.1
RAPID GROWTH OF SUPPLEMENTS INDUSTRY IN SOUTH KOREA
 
 
 
 
 
14.4.5
REST OF ASIA PACIFIC
 
 
 
 
 
14.5
SOUTH AMERICA
 
 
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
 
 
 
14.5.1.1
GROWTH IN AWARENESS REGARDING THE BENEFITS OF FUNCTIONAL FOODS AND RISE IN AGING POPULATION IN BRAZIL
 
 
 
 
 
14.5.2
ARGENTINA
 
 
 
 
 
 
 
14.5.2.1
COUNTRY’S FOCUS ON PREVENTION HEALTHCARE SYSTEM TO BE POSITIVE SIGN FOR NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
14.5.3
REST OF SOUTH AMERICA
 
 
 
 
 
14.6
REST OF THE WORLD (ROW)
 
 
 
 
 
 
 
14.6.1
MIDDLE EAST
 
 
 
 
 
 
 
14.6.1.1
RISE IN OBESITY AND OTHER HEALTH-RELATED CONCERNS IN MIDDLE EAST
 
 
 
 
 
14.6.2
AFRICA
 
 
 
 
 
 
 
14.6.2.1
INTRA-AFRICAN TRADE POLICIES AND INVESTMENTS BY GLOBAL NUTRACEUTICAL PLAYERS
 
 
 
15
COMPETITIVE LANDSCAPE
Discover market leaders' strategies and performance metrics shaping competitive dynamics through 2024.
 
 
 
 
 
258
 
15.1
OVERVIEW
 
 
 
 
 
 
15.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020–2024
 
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
 
15.5
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
 
15.5.1
KERRY GROUP PLC (IRELAND)
 
 
 
 
 
 
15.5.2
INGREDION (US)
 
 
 
 
 
 
15.5.3
BASF (GERMANY)
 
 
 
 
 
 
15.5.4
ASSOCIATED BRITISH FOODS PLC (UK)
 
 
 
 
 
 
15.5.5
SENSIENT TECHNOLOGIES CORPORATION (US)
 
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
 
 
15.6.1
STARS
 
 
 
 
 
 
15.6.2
EMERGING LEADERS
 
 
 
 
 
 
15.6.3
PERVASIVE PLAYERS
 
 
 
 
 
 
15.6.4
PARTICIPANTS
 
 
 
 
 
 
15.6.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
 
 
15.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
15.6.5.2
REGION FOOTPRINT
 
 
 
 
 
 
15.6.5.3
SOURCE FOOTPRINT
 
 
 
 
 
 
15.6.5.4
FUNCTIONALITY FOOTPRINT
 
 
 
 
 
 
15.6.5.5
FUNCTIONALITY APPLICATION FOOTPRINT
 
 
 
 
15.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
 
15.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
15.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
15.7.3
DYNAMIC COMPANIES
 
 
 
 
 
 
15.7.4
STARTING BLOCKS
 
 
 
 
 
 
15.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
15.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
15.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
15.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
 
15.8.1
COMPANY VALUATION
 
 
 
 
 
 
15.8.2
EV/EBITDA
 
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
15.9.2
DEALS
 
 
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
 
 
15.9.4
OTHER DEVELOPMENTS
 
 
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
284
 
16.1
KEY PLAYERS
 
 
 
 
 
 
 
16.1.1
KERRY GROUP PLC
 
 
 
 
 
 
 
16.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
16.1.1.2
PRODUCT/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
16.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
16.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
16.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
16.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
16.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
16.1.2
INGREDION
 
 
 
 
 
 
16.1.3
BASF SE
 
 
 
 
 
 
16.1.4
ASSOCIATED BRITISH FOODS PLC
 
 
 
 
 
 
16.1.5
SENSIENT TECHNOLOGIES CORPORATION
 
 
 
 
 
 
16.1.6
CARGILL, INCORPORATED
 
 
 
 
 
 
16.1.7
AZELIS
 
 
 
 
 
 
16.1.8
ASHLAND
 
 
 
 
 
 
16.1.9
MEGGLE HOLDING SE
 
 
 
 
 
 
16.1.10
ROQUETTE FRÈRES
 
 
 
 
 
 
16.1.11
COLORCON, INC.
 
 
 
 
 
 
16.1.12
ALSIANO A/S
 
 
 
 
 
 
16.1.13
JIGS CHEMICAL
 
 
 
 
 
 
16.1.14
IMCD
 
 
 
 
 
 
16.1.15
HILMAR CHEESE COMPANY, INC.
 
 
 
 
 
 
16.1.16
OMYA
 
 
 
 
 
 
16.1.17
BIOGRUND
 
 
 
 
 
 
16.1.18
JRS PHARMA
 
 
 
 
 
 
16.1.19
INNOPHOS
 
 
 
 
 
 
16.1.20
NOVO EXCIPIENTS PVT. LTD.
 
 
 
 
 
 
16.1.21
PANCHAMRUT CHEMICALS
 
 
 
 
 
 
16.1.22
GATTEFOSSÉ
 
 
 
 
 
 
16.1.23
FUJI CHEMICAL INDUSTRIES CO., LTD.
 
 
 
 
 
 
16.1.24
SUDEEP PHARMA LIMITED
 
 
 
 
 
 
16.1.25
SORSE TECHNOLOGIES
 
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
378
 
17.1
RESEARCH DATA
 
 
 
 
 
 
 
17.1.1
SECONDARY DATA
 
 
 
 
 
 
 
17.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
17.1.2
PRIMARY DATA
 
 
 
 
 
 
 
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
17.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
 
 
 
17.1.2.2.1
NUTRACEUTICAL EXCIPIENTS COMPANIES
 
 
 
 
17.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
17.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
17.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
17.2.2
TOP-DOWN APPROACH
 
 
 
 
 
 
17.2.3
TOP-DOWN APPROACH
 
 
 
 
 
17.3
DATA TRIANGULATION
 
 
 
 
 
 
17.4
FACTOR ANALYSIS
 
 
 
 
 
 
17.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
17.6
RESEARCH LIMITATIONS
 
 
 
 
 
18
APPENDIX
 
 
 
 
 
392
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.3
RELATED REPORTS
 
 
 
 
 
 
18.4
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
USD EXCHANGE RATES, 2020–2024
 
 
 
 
 
 
TABLE 3
GLOBAL PREVALENCE OF ANEMIA, 2024–2025
 
 
 
 
 
 
TABLE 4
UNMET NEEDS AND WHITE SPACES IN NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
TABLE 5
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
TABLE 6
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
TABLE 7
NUTRACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 8
NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
 
 
 
 
 
 
TABLE 9
INDICATIVE AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL EXCIPIENTS BY KEY PLAYERS, 2024 (USD/MT)
 
 
 
 
 
 
TABLE 10
INDICATIVE PRICING ANALYSIS FOR NUTRACEUTICAL EXCIPIENTS, BY SOURCE, 2023–2024 (USD/KG)
 
 
 
 
 
 
TABLE 11
AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2024 (USD/KG)
 
 
 
 
 
 
TABLE 12
NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
 
 
 
 
 
 
TABLE 13
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 14
EXPECTED IMPACT LEVEL ON TARGET PRODUCTS WITH RELEVANT HS CODES DUE TO TRUMP TARIFF IMPACT
 
 
 
 
 
 
TABLE 15
EXPECTED TARIFF IMPACT ON END-USE INDUSTRIES: NUTRACEUTICAL EXCIPIENT
 
 
 
 
 
 
TABLE 16
TECHNOLOGY/PRODUCT MAP FOR NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
TABLE 17
LIST OF MAJOR PATENTS ABOUT NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2024
 
 
 
 
 
 
TABLE 18
NUTRACEUTICAL EXCIPIENTS MARKET: FUTURE APPLICATIONS
 
 
 
 
 
 
TABLE 19
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 23
ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE
 
 
 
 
 
 
TABLE 25
DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
 
 
 
 
 
 
TABLE 26
SCHEDULE – XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS
 
 
 
 
 
 
TABLE 27
LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
 
 
 
 
 
 
TABLE 28
KEY INDUSTRY STANDARDS FOR NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
TABLE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT SOURCE
 
 
 
 
 
 
TABLE 30
KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT
 
 
 
 
 
 
TABLE 31
NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 32
NUTRACEUTICAL EXCIPIENTS MARKET, BY MATERIAL, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 33
NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 34
NUTRACEUTICAL EXCIPIENTS MARKET IN PROBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 35
NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 36
NUTRACEUTICAL EXCIPIENTS MARKET IN PREBIOTICS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 37
NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 38
NUTRACEUTICAL EXCIPIENTS MARKET IN PROTEINS & AMINO ACIDS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 39
LIST OF NUTRIENTS AND THEIR RELEVANCE
 
 
 
 
 
 
TABLE 40
NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 41
NUTRACEUTICAL EXCIPIENTS MARKET IN VITAMINS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 42
NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 43
NUTRACEUTICAL EXCIPIENTS MARKET IN MINERALS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 44
NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 45
NUTRACEUTICAL EXCIPIENTS MARKET IN OMEGA-3 FATTY ACIDS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 46
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 47
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER END PRODUCTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 48
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 49
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 50
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 51
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 52
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 53
ORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 54
OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 55
OLEOCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 56
CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 57
CARBOHYDRATE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 58
SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 59
SUGAR-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 60
CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 61
CELLULOSE-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 62
STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 63
STARCH-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 64
PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 65
PETROCHEMICAL NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 66
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 67
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 68
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 69
INORGANIC NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 70
OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 71
OTHER CHEMICAL-BASED NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 72
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 73
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 74
NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 75
NUTRACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 77
NUTRACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 78
NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 79
NUTRACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 80
NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 81
NUTRACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY ENHANCEMENT, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 82
NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 83
NUTRACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 84
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 85
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 86
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 87
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 88
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 89
DRY NUTRACEUTICAL EXCIPIENTS MARKET, BY DRY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 90
LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 91
LIQUID NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 92
OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 93
OTHER NUTRACEUTICAL EXCIPIENT FORMULATIONS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NUTRACEUTICAL EXCIPIENTS MARKET IN BINDERS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NUTRACEUTICAL EXCIPIENTS MARKET IN FILLERS & DILUENTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NUTRACEUTICAL EXCIPIENTS MARKET IN DISINTEGRANTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 102
NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 103
NUTRACEUTICAL EXCIPIENTS MARKET IN COATING AGENTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 105
NUTRACEUTICAL EXCIPIENTS MARKET IN FLAVORING AGENTS & SWEETENERS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 106
NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 107
NUTRACEUTICAL EXCIPIENTS MARKET IN PRESERVATIVES, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 109
NUTRACEUTICAL EXCIPIENTS MARKET IN LUBRICANTS & GLIDANTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 110
NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 111
NUTRACEUTICAL EXCIPIENTS MARKET IN SUSPENDING & VISCOSITY AGENTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 112
NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 113
NUTRACEUTICAL EXCIPIENTS MARKET IN COLORANTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 114
NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 115
NUTRACEUTICAL EXCIPIENTS MARKET IN EMULSIFYING AGENTS, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 116
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 117
NUTRACEUTICAL EXCIPIENTS MARKET IN OTHER FUNCTIONALITIES, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 118
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 119
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 120
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (KT)
 
 
 
 
 
 
TABLE 121
NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (KT)
 
 
 
 
 
 
TABLE 122
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 123
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 124
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 125
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 126
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 127
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 128
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 129
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 130
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 131
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 132
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 133
NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 134
US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 135
US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 136
CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 137
CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 138
MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 139
MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 140
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 141
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 142
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 143
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 144
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 145
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 146
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 147
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 148
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 149
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 150
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 152
GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 153
GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 154
FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 155
FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 156
UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 157
UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 159
ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 160
SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 161
SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 162
REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 163
REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 164
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 165
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 166
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 167
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 168
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 169
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 170
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 171
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 172
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 173
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 174
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 175
ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 176
CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 177
CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 178
JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 179
JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 180
INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 181
INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 182
SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 183
SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 184
REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 185
REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 186
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 187
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 188
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 189
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 190
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 191
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 192
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 193
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 194
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 195
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 196
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 197
SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 198
BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 199
BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 200
ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 201
ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 202
REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 203
REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 204
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 205
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 206
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 208
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 209
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 210
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 211
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 212
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 213
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 214
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 216
MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 217
MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 218
AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 219
AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 220
COMPETITIVE STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2024
 
 
 
 
 
 
TABLE 221
NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 222
NUTRACEUTICAL EXCIPIENTS MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 223
NUTRACEUTICAL EXCIPIENTS MARKET: SOURCE FOOTPRINT
 
 
 
 
 
 
TABLE 224
NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY FOOTPRINT
 
 
 
 
 
 
TABLE 225
NUTRACEUTICAL EXCIPIENTS MARKET: FUNCTIONALITY APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 226
NUTRACEUTICAL EXCIPIENTS MARKET: KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 227
NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
 
 
 
 
 
 
TABLE 228
NUTRACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, 2020–NOVEMBER 2025
 
 
 
 
 
 
TABLE 229
NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2020–NOVEMBER 2025
 
 
 
 
 
 
TABLE 230
NUTRACEUTICAL EXCIPIENTS MARKET: EXPANSIONS, 2020–NOVEMBER 2025
 
 
 
 
 
 
TABLE 231
NUTRACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, 2020–NOVEMBER 2025
 
 
 
 
 
 
TABLE 232
KERRY GROUP PLC: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 233
KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 234
KERRY GROUP PLC: DEALS
 
 
 
 
 
 
TABLE 235
KERRY GROUP PLC: EXPANSION
 
 
 
 
 
 
TABLE 236
INGREDION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 237
INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 238
INGREDION: DEALS
 
 
 
 
 
 
TABLE 239
BASF SE: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 240
BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 241
BASF SE: DEALS
 
 
 
 
 
 
TABLE 242
BASF SE: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 243
ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 244
ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 245
ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 246
SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 247
SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 248
SENSIENT TECHNOLOGIES CORPORATION: DEALS
 
 
 
 
 
 
TABLE 249
CARGILL, INCORPORATED: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 250
CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 251
CARGILL, INCORPORATED: EXPANSIONS
 
 
 
 
 
 
TABLE 252
AZELIS: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 253
AZELIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 254
AZELIS: DEALS
 
 
 
 
 
 
TABLE 255
AZELIS: EXPANSIONS
 
 
 
 
 
 
TABLE 256
ASHLAND: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 257
ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 258
ASHLAND: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 259
ASHLAND: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 260
MEGGLE HOLDING SE: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 261
MEGGLE HOLDING SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 262
MEGGLE HOLDING SE: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 263
ROQUETTE FRÈRES: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 264
ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 265
ROQUETTE FRÈRES: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 266
ROQUETTE FRÈRES: DEALS
 
 
 
 
 
 
TABLE 267
ROQUETTE FRÈRES: EXPANSIONS
 
 
 
 
 
 
TABLE 268
COLORCON, INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 269
COLORCON, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 270
COLORCON, INC.: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 271
COLORCON, INC.: DEALS
 
 
 
 
 
 
TABLE 272
COLORCON, INC.: EXPANSIONS
 
 
 
 
 
 
TABLE 273
COLORCON, INC.: OTHER DEVELOPMENTS
 
 
 
 
 
 
TABLE 274
ALSIANO A/S: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 275
ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 276
ALSIANO A/S: DEALS
 
 
 
 
 
 
TABLE 277
JIGS CHEMICAL: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 278
JIGS CHEMICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 279
IMCD: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 280
IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 281
IMCD: DEALS
 
 
 
 
 
 
TABLE 282
IMCD: EXPANSIONS
 
 
 
 
 
 
TABLE 283
HILMAR CHEESE COMPANY, INC.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 284
HILMAR CHEESE COMPANY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 285
HILMAR CHEESE COMPANY, INC.: EXPANSIONS
 
 
 
 
 
 
TABLE 286
OMYA: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 287
OMYA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 288
OMYA: DEALS
 
 
 
 
 
 
TABLE 289
BIOGRUND: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 290
BIOGRUND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 291
BIOGRUND: DEALS
 
 
 
 
 
 
TABLE 292
BIOGRUND: EXPANSIONS
 
 
 
 
 
 
TABLE 293
JRS PHARMA: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 294
JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 295
JRS PHARMA: PRODUCT LAUNCHES
 
 
 
 
 
 
TABLE 296
JRS PHARMA: EXPANSIONS
 
 
 
 
 
 
TABLE 297
INNOPHOS: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 298
INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 299
INNOPHOS: EXPANSIONS
 
 
 
 
 
 
TABLE 300
NOVO EXCIPIENTS PVT. LTD.: BUSINESS OVERVIEW
 
 
 
 
 
 
TABLE 301
NOVO EXCIPIENTS PVT. LTD.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 302
PANCHAMRUT CHEMICALS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 303
GATTEFOSSÉ: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 304
FUJI CHEMICAL INDUSTRIES CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 305
SUDEEP PHARMA LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 306
SORSE TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
STUDY YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
KEY INSIGHTS AND MARKET HIGHLIGHTS
 
 
 
 
 
 
FIGURE 4
GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET, 2021–2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2020–2025
 
 
 
 
 
 
FIGURE 6
DISRUPTIVE TRENDS IMPACTING GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS AND EMERGING FRONTIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, 2025–2030
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
INCREASING DEMAND FOR HIGH-QUALITY EXCIPIENTS ENABLING EFFECTIVE TABLET AND CAPSULE NUTRACEUTICAL FORMULATIONS
 
 
 
 
 
 
FIGURE 10
ORGANIC CHEMICALS SEGMENT AND NORTH AMERICA ACCOUNTED FOR LARGEST SEGMENTAL SHARES IN 2024
 
 
 
 
 
 
FIGURE 11
NORTH AMERICA DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
 
 
 
 
 
 
FIGURE 12
DRY SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
 
 
 
 
 
 
FIGURE 13
ORGANIC CHEMICALS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
 
 
 
 
 
 
FIGURE 14
MODIFIED RELEASE SEGMENTS DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
 
 
 
 
 
 
FIGURE 15
PROBIOTICS SEGMENT DOMINATED NUTRACEUTICAL EXCIPIENTS MARKET IN 2024
 
 
 
 
 
 
FIGURE 16
INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 17
NUTRACEUTICAL EXCIPIENTS MARKET DYNAMICS
 
 
 
 
 
 
FIGURE 18
NUMBER OF AMERICANS WITH CHRONIC CONDITIONS, 1995–2030 (MILLION)
 
 
 
 
 
 
FIGURE 19
PORTER’S FIVE FORCES ANALYSIS: NUTRACEUTICAL EXCIPIENTS MARKET
 
 
 
 
 
 
FIGURE 20
US: POPULATION AGED 65 AND OLDER, 2000–2060 (MILLION)
 
 
 
 
 
 
FIGURE 21
KEY MARKET DRIVERS SHAPING INNOVATION, ADOPTION, AND GROWTH DYNAMICS ACROSS GLOBAL NUTRACEUTICAL EXCIPIENT INDUSTRY IN RESPONSE TO EVOLVING FORMULATION DEMANDS
 
 
 
 
 
 
FIGURE 22
NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 23
NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
 
 
 
 
 
 
FIGURE 24
AVERAGE SELLING PRICE TREND, BY REGION, 2020–2024 (USD/KG)
 
 
 
 
 
 
FIGURE 25
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 26
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 210690 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 27
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 28
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 300490 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 29
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 30
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 293090 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 31
EXPORT VALUE OF NUTRACEUTICAL EXCIPIENTS UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 32
IMPORT VALUE OF NUTRACEUTICAL EXCIPIENT UNDER HS CODE 382200 FOR KEY COUNTRIES, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
FIGURE 33
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS
 
 
 
 
 
 
FIGURE 34
INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION)
 
 
 
 
 
 
FIGURE 35
NUMBER OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024
 
 
 
 
 
 
FIGURE 36
REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2014–2024
 
 
 
 
 
 
FIGURE 37
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR NUTRACEUTICAL EXCIPIENT TYPE
 
 
 
 
 
 
FIGURE 38
KEY BUYING CRITERIA FOR NUTRACEUTICAL EXCIPIENT END PRODUCT
 
 
 
 
 
 
FIGURE 39
PROTEIN & AMINO ACIDS TO LEAD DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 40
NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 41
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2025 VS. 2030
 
 
 
 
 
 
FIGURE 42
NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 43
NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 44
ITALY, CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 45
NORTH AMERICA: MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 46
ASIA PACIFIC: MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 47
NUTRACEUTICAL EXCIPIENTS MARKET: REVENUE ANALYSIS FOR FIVE KEY PLAYERS, 2022–2024 (USD BILLION)
 
 
 
 
 
 
FIGURE 48
SHARE OF LEADING COMPANIES IN NUTRACEUTICAL EXCIPIENTS MARKET, 2024
 
 
 
 
 
 
FIGURE 49
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 50
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
 
 
FIGURE 51
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 52
NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
 
 
FIGURE 53
COMPANY VALUATION OF KEY NUTRACEUTICAL EXCIPIENTS MANUFACTURERS
 
 
 
 
 
 
FIGURE 54
EV/EBITDA OF KEY COMPANIES
 
 
 
 
 
 
FIGURE 55
KERRY GROUP PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 56
INGREDION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 57
BASF SE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 58
ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 59
SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 60
CARGILL, INCORPORATED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 61
AZELIS: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 62
ASHLAND: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 63
ROQUETTE FRÈRES: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 64
IMCD: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 65
NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 66
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 67
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 68
KEY INSIGHTS FROM INDUSTRY EXPERTS
 
 
 
 
 
 
FIGURE 69
BRIEF OF BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 70
NUTRACEUTICAL EXCIPIENTS MARKET: BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 71
NUTRACEUTICAL EXCIPIENTS MARKET: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 72
BRIEF OF TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 73
DATA TRIANGULATION
 
 
 
 
 
 
FIGURE 74
FACTOR ANALYSIS
 
 
 
 
 
 
FIGURE 75
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
FIGURE 76
RESEARCH LIMITATIONS
 
 
 
 
 
 

Methodology

The study employed two primary approaches to estimate the current size of the nutraceutical excipients market. Exhaustive secondary research was conducted to gather information on the market, peer markets, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

This research study involved the extensive use of secondary sources, directories, and databases such as Bloomberg Businessweek and Factiva, to identify and collect information useful for a technical, market-oriented, and commercial study of the market.

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases were referred to to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.

Primary Research

Extensive primary research was conducted after obtaining information regarding the nutraceutical excipients market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to source, end product, functionality, functionality application, formulation, and technology. Stakeholders from the demand side, such as research institutions and universities, and third-party vendors, were interviewed to understand the buyer’s perspective on the service, and their current usage of nutraceutical excipients and the outlook of their business, which will affect the overall market.

Breakdown of Primary Interviews

Nutraceutical Excipients Market

Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, as per the availability of financial data: Tier 1: Revenue >USD 1 billion; Tier 2: USD 100 million ≤ Revenue ≤ USD 1 billion; Tier 3: Revenue < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
BASF SE (Germany) R&D Expert
Cargill, Incorporated (US Sales Manager
ADM (US) Manager
Corbion (Netherlands) Sales Manager
Eastman Chemical Company (US) Marketing Manager

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of the nutraceutical excipients market. These approaches were also used extensively to determine the size of various subsegments in the market. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and the overall markets were identified through extensive secondary research.
  • All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.
  • The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.

Nutraceutical Excipients Market: Bottom-up & Top-down Approaches

Nutraceutical Excipients Market

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall nutraceutical excipients market and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.

Market Definition

Nutraceutical excipients are inactive ingredients that are added to nutraceutical formulations. These excipients help to improve the effectiveness of active ingredients in the final product. Nutraceutical active ingredients are functional components that support the nutrition and health of the human body. They are often used to supplement the nutrients that we get from our regular diet. Excipients play an important role in delivering nutraceutical components accurately and on time. They also maintain the optimum levels of active ingredients in the nutraceutical products, such as vitamins and minerals.

Stakeholders

  • Raw material supplier
  • Commercial R&D institutions
  • Manufacturers, dealers, and suppliers in the nutraceutical excipients market
  • Government bodies
  • Food & beverage manufacturers
  • Nutraceutical manufacturers
  • Cosmetic & skincare product manufacturers
  • Food importers and exporters
  • Associations and NGOs
  • Logistics providers & transporters
  • Regulatory bodies & institutions
  • US Food and Drug Administration (US FDA)
  • European Food Safety Authority (EFSA)
  • Food Safety and Standards Authority of India (FSSAI)
  • Food Safety Law of the People’s Republic of China
  • Food Safety Commission of Japan

Report Objectives

  • To determine, define, and project the size of the nutraceutical excipients market, with respect to source, end product, functionality, functionality application, formulation, technology, and regional markets, over five years, ranging from 2025 to 2030
  • To identify the attractive opportunities in the market by determining the largest and fastest-growing segments across regions
  • To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To analyze the micro markets with respect to individual growth trends, prospects, and their contribution to the total market
  • To strategically profile key market players and comprehensively analyze their core competencies in each segment
  • To track and analyze competitive developments, such as alliances, joint ventures, new product developments, mergers, and acquisitions, in the nutraceutical excipients market

 

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Nutraceutical Excipients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Nutraceutical Excipients Market

DMCA.com Protection Status